U.S. Wireless Telecom Stock News

Lam Research stock has delivered a very large 5 year gain, yet the current valuation checks suggest it no longer screens as a clear bargain, with recent swings in sector sentiment adding another layer of uncertainty for investors trying to judge what the current price is baking in. Lam Research has returned about 5x over the past 5 years, which raises the bar for any further upside to be justified by future cash flows and earnings power. Strong demand for semiconductor equipment tied to AI...

On 9 July 2026, Otsuka ICU Medical LLC announced plans to invest over US$500 million to expand IV solutions manufacturing in Austin, Texas, adding a new 500,000-square-foot facility and upgrading its existing 700,000-square-foot site to support non-DEHP containers and future innovation. This large-scale build-out aims to improve North American supply resiliency for IV solutions while aligning the joint venture with evolving non-DEHP legislation and regulatory expectations. Next, we’ll...

Enovix Corporation recently appointed Dr. Michael Vyvoda, a former Apple Director of Product Operations with extensive manufacturing experience, as Chief Operating Officer, consolidating global manufacturing, supply chain and operations engineering under his leadership. His background in scaling AirPods to high-volume production and driving cost reductions could be especially relevant as Enovix builds out facilities in Malaysia and Korea with R&D support from India. We’ll now examine how...

SEI Investments (SEIC) drew fresh attention after launching the SEI QiM U.S. Equity Factor Allocation Active ETF, a core U.S. equity product built on its quantitative factor allocation research and risk framework. See our latest analysis for SEI Investments. SEI Investments shares trade at $94.89 after a slight pullback over the past day and week, although a 6.14% 1 month share price return and 18.60% 3 month share price return suggest momentum has been building, supported by a 5.38% 1 year...

Nuclear energy stocks sit at the crossroads of power security, inflation concerns and shifting interest rate expectations, as investors look for assets tied to essential infrastructure and long term energy demand. With inflation signals mixed across the US, Europe and Asia, and sovereign yields moving on each new data release, some investors are revisiting nuclear as a potential source of more predictable cash flows within the wider energy mix. This Nuclear Energy Stocks screener highlights...

Cincinnati Financial recently attracted attention as analysts highlighted its history of beating earnings expectations and pointed to indicators suggesting another potential earnings beat in its upcoming report, even as consensus sees only modest book value per share growth ahead. This mix of strong recent execution against estimates and relatively muted expectations for future balance sheet expansion raises questions about how much earnings surprise potential remains embedded in the...

Short seller report alleges Bloom Energy relies on undisclosed Chinese sources for scandium used in its fuel cells. Bloom Energy strongly denies the claims, emphasizing its view of supply chain integrity and compliance. Analyst sentiment remains broadly supportive, with bullish views persisting as AI data center demand hits record levels. Bloom Energy (NYSE:BE) is back in focus after this latest supply chain dispute, coming at a time when the stock has already moved sharply over the past...

Thermal camera contract puts Leonardo DRS stock in focus Leonardo DRS (DRS) has drawn investor attention after announcing a contract to supply more than 50,000 Tenum Orbit thermal imaging cameras under a blanket purchase agreement. The deal marks a production milestone for Leonardo DRS, tied to what the company describes as growing demand for compact thermal imaging systems across unmanned systems and other fast-evolving platforms. See our latest analysis for Leonardo DRS. Alongside the...

On July 10, 2026, Pfizer and Astellas said the FDA approved PADCEV plus Keytruda or Keytruda QLEX as the first platinum‑free neoadjuvant and adjuvant regimen for adult muscle‑invasive bladder cancer patients, regardless of cisplatin eligibility. This decision broadens PADCEV’s role from later‑stage disease into earlier, curative‑intent treatment, potentially deepening Pfizer’s presence in bladder cancer care pathways. We’ll now examine how this earlier‑stage PADCEV‑Keytruda approval fits...

Consolidated Edison (NYSE:ED) has elected Tali Farhadian to its Board of Directors. Farhadian brings extensive legal and regulatory experience from public service and legal academia. She has been involved with major New York civic institutions, adding local policy insight to the board. The appointment is intended to strengthen governance and oversight at the utility company. Consolidated Edison, the regulated utility behind electricity, gas, and steam service in New York, operates in a...

AI Infrastructure Stocks sit at the heart of the AI story, turning abstract algorithms into real-world power, cooling and connectivity. With inflation trends split across regions, policy rates moving in different directions and energy still a swing factor, many investors are looking for business models that are tied to essential capacity rather than hype. This AI Infrastructure Stocks screener focuses on companies that convert AI demand into actual revenue and cash generation. In this...

Generac Holdings (GNRC) is back in focus after promoting Niccolò Borracchini to Executive Vice President, International, as long serving leader Paolo Campinoti steps back into an advisory role. See our latest analysis for Generac Holdings. The leadership change comes as Generac Holdings trades at US$225.12, with the share price down 14.19% over the past 30 days but still showing a 59.55% year to date share price return and a 53.34% 1 year total shareholder return. This suggests strong longer...

Mastercard is reportedly exploring a sale of a majority stake in its UK payments infrastructure subsidiary, Vocalink. The potential deal would return primary control of key UK payment rails to British banks. The review comes amid ongoing debate in the UK about foreign ownership of critical national payment systems. For investors watching Mastercard (NYSE:MA), this potential reshaping of its UK footprint comes with the stock trading at $538.02 after a 9.8% gain over the past month and a...

In recent weeks, Digital Realty Trust raised fresh capital through a follow-on offering, acquired data center stakes from Blackstone, and was honored as Outstanding Company of the Year at the 2025–2026 Asia Pacific Business Awards, recognizing its expanding AI-ready infrastructure footprint. Together, these moves highlight how Digital Realty is using new funding and acquisitions to deepen its role in global AI-focused digital infrastructure while gaining regional leadership recognition in...

IBM’s second quarter earnings warning, which points to tighter enterprise software budgets and higher hardware spending, quickly pressured monday.com (MNDY) stock, even though the company’s underlying business growth and earnings expectations have remained relatively stable. See our latest analysis for monday.com. The IBM warning added pressure to a stock that was already weak, with monday.com’s share price down 42.94% year to date and the 1 year total shareholder return falling 71.20%. This...

Recently, options trading in Pathward Financial, Inc. saw unusually high implied volatility in the September 18, 2026 $100 call contracts, signaling expectations of a sizeable move in the shares despite a current Zacks Rank #3 (Hold). This elevated options activity has drawn attention precisely because it emerged without accompanying material company announcements, highlighting how derivatives markets can sometimes spotlight shifting sentiment before new information becomes public. Next,...

Recent Stock Move and Upcoming Earnings Focus Marathon Petroleum (MPC) has drawn attention after a 2.2% gain in its latest session to $303.40, extending an 18% rise over the past month as investors look ahead to its August 4 earnings report. See our latest analysis for Marathon Petroleum. For context, Marathon Petroleum’s recent 18% one month share price return builds on strong momentum, with a year to date share price return of 83.72% and a five year total shareholder return above 500%. If...

CoreWeave (NasdaqGS:CRWV) is facing a lawsuit alleging securities law violations related to disclosures on operational risks and revenue impact. The company is contending with direct competition from Meta Platforms, which has shifted from being a major CoreWeave customer to offering rival cloud AI services. CoreWeave is exploring financial hedging strategies tied to memory chip supply agreements to help manage exposure to future pricing swings. CoreWeave, traded as NasdaqGS:CRWV, now sits...

Global inflation, shifting rate expectations and energy price swings are pushing investors to look closely at real-world businesses connected to long-term government spending and essential services. The Aerospace And Defense screener focuses on companies that manufacture or provide services to the sector, an area closely watched whenever geopolitical risk and fiscal priorities stay in the headlines. With inflation readings, bond yields and policy signals moving in different directions across...

Stronger second quarter investment banking and trading revenues across big banks have put Moelis (MC) in focus after its stock gained 4.4%, as merger, acquisition, and IPO fees reached their highest levels since 2021. See our latest analysis for Moelis. At a share price of $66.97, Moelis has seen a 1-day share price return of 5.28%, while the year to date share price return is down 5.97%. The 5-year total shareholder return of 58.99% shows that longer term holders have still been rewarded...

Agios Pharmaceuticals (AGIO) is back in focus after the U.S. Food and Drug Administration accepted its supplemental New Drug Application for mitapivat in sickle cell disease under Priority Review, using the accelerated approval pathway. See our latest analysis for Agios Pharmaceuticals. At a share price of US$39.92, Agios Pharmaceuticals has had a 30 day share price return of 35.51% and a year to date share price return of 46.87%. The 1 year total shareholder return of 1.86% suggests momentum...

China Yuchai International Limited’s Board of Directors declared a cash dividend of US$0.87 per ordinary share for the year ended December 31, 2025, payable on July 28, 2026 to shareholders of record on July 17, 2026. This higher cash payout highlights how the company is using its balance sheet to return more capital to shareholders through dividends. We’ll now examine how this higher cash dividend, and what it implies about capital allocation, could influence China Yuchai’s investment...

RXO (RXO) has drawn fresh attention after announcing a partnership with Highway Inc., a Carrier Identity technology provider, aimed at tightening fraud prevention, improving in transit visibility, and supporting more secure freight operations. See our latest analysis for RXO. The RXO share price has climbed 3.51% over the past day and 4.35% over the week, while the 90 day share price return of 70.25% and year to date share price return of 118.38% point to strong momentum, set against a 1 year...

American Water Works Company stock is back near US$131, yet the valuation picture is uneasy, with a Dividend Discount Model (DDM) estimate pointing to a premium price while the broader checks do not flag the shares as a clear bargain. Over the past 5 years, American Water Works Company shareholders have seen the stock decline 12.4%, which raises the bar for today’s price to be supported by robust long term cash flows. Planned wastewater and water infrastructure investments, including the...